Allan J Darling from Oakland, MD, age 64

Allan Cuthberts

view source

Born Allan Darling Cuthbertson in Perth, Western Australia, he performed on stage and radio ... http://www.filmreference.com/film/35/Allan-Cuthbertson.html ...

Us Patents

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20220280550, Sep 8, 2022
Filed:

May 16, 2022
Appl. No.:

17/745464
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20220280551, Sep 8, 2022
Filed:

May 16, 2022
Appl. No.:

17/745487
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20220280552, Sep 8, 2022
Filed:

May 16, 2022
Appl. No.:

17/745491
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20220280553, Sep 8, 2022
Filed:

May 16, 2022
Appl. No.:

17/745497
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20220280554, Sep 8, 2022
Filed:

May 16, 2022
Appl. No.:

17/745505
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20220273697, Sep 1, 2022
Filed:

May 16, 2022
Appl. No.:

17/745470
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20230095371, Mar 30, 2023
Filed:

Nov 30, 2022
Appl. No.:

18/072260
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Hydroxypropyl Beta-Cyclodextrin Compositions And Methods
view source
US Patent:

20230068856, Mar 2, 2023
Filed:

Oct 20, 2022
Appl. No.:

17/970080
Inventors:

- West Hollywood CA, US
Allan Darling - North Potomac MD, US
International Classification:

A61K 31/724
A61K 9/00
A61K 9/08
Abstract:

This disclosure provides mixtures of beta-cyclodextrin molecules substituted at one or more hydroxyl positions by hydroxypropyl groups, the mixture optionally including unsubstituted beta-cyclodextrin molecules, for use as a pharmaceutically active ingredient; methods of making such mixtures; methods of qualifying such mixtures for use in a pharmaceutical composition suitable for intrathecal or intracerebroventricular administration; pharmaceutical compositions suitable for intrathecal or intracerebroventricular administration comprising such mixtures; and methods of using the pharmaceutical compositions for treatment of Niemann-Pick disease Type C.

Vehicle Records

Allan Darling
view source
Address:

14031 Welland Ter, North Potomac, MD 20878
VIN:

WVWRU73C88E141276
Make:

VOLKSWAGEN
Model:

PASSAT
Year:

2008

Allan Darling

view source

Location:

1218 3Rd St, Langdon, ND 58249

Industry:

Biotechnology

Work:

Vtesse, Inc. Jan 2015 - Jun 2017
Vice President Technical Operations
Caledonian Consulting Apr 2012 - Dec 2014
Chief Executive Officer
Medimmune Apr 2006 - Apr 2012
Vice President Technical Operations and Qc
Bioreliance 1995 - 2005
Senior Vice President Operations

Education:

University of Dundee 1982 - 1985
Doctorates, Doctor of Philosophy University of Dundee Jan 1, 1977 - 1981
Doctorates, Doctor of Philosophy University of Edinburgh School of Philosophy, Psychology and Language Sciences Jan 1, 1977 - 1981
Bachelors, Bachelor of Science, Microbiology

Skills:

Technology Transfer
Biotechnology
Gmp
Validation
Fda
Lifesciences
Pharmaceutical Industry
Sop
V&V
Change Control
Capa
Contract Manufacturing
Regulatory Affairs
Quality Assurance
Biopharmaceuticals
Drug Development
Vaccines
Commercialization
Elisa
Glp
Life Sciences
Medical Devices

Languages:

English